Yang-Hee Joo
Overview
Explore the profile of Yang-Hee Joo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee K, Jung S, Joo Y, Song E, Moon C, Kim S, et al.
PLoS One
. 2019 Dec;
14(12):e0225739.
PMID: 31790467
Tonsil-derived mesenchymal stem cells (TMSC) have characteristics of MSC and have many advantages. In our previous studies, intraperitoneal (IP) injection of TMSC in acute and chronic colitis mouse models improved...
2.
Chang J, Kim S, Kim T, Woo S, Ryu M, Joo Y, et al.
PLoS One
. 2017 Oct;
12(10):e0186120.
PMID: 28982166
Objectives: Rifaximin, a poorly absorbed antibiotics, has gut-specific therapeutic effects. Although frequently prescribed to manipulate intestinal luminal bacterial population in various diseases, the possible induction of antibacterial cross-resistance to a...
3.
Yu Y, Song E, Lee K, Joo Y, Kim S, Moon C, et al.
PLoS One
. 2017 Aug;
12(8):e0183141.
PMID: 28854223
The therapeutic potential of tonsil-derived mesenchymal stem cells (TMSC) prepared from human tonsillar tissue has been studied in animal models for several diseases such as hepatic injury, hypoparathyroidism, diabetes and...
4.
Tae C, Shim K, Kim H, Joo Y, Lee J, Cho M, et al.
Scand J Gastroenterol
. 2015 Jul;
51(1):67-72.
PMID: 26153034
Objective: The calcium-sensing receptor (CaSR) is known to have differential expression in various carcinomas and normal tissues. It has been shown to be involved in carcinogenesis or tumor suppression. However,...
5.
Tae C, Kim S, Jung S, Joo Y, Shim K, Jung H, et al.
BMC Cancer
. 2014 Nov;
14:811.
PMID: 25370174
Background: Although altered levels of adiponectin have been reported as a potential risk factor in colorectal cancer (CRC), the importance of the role played by adiponectin in colorectal carcinogenesis has...
6.
Ryu K, Shim K, Jung S, Yoo K, Joo Y, Lee J
Korean J Gastroenterol
. 2012 Oct;
60(4):229-41.
PMID: 23089909
Background/aims: The aims of this study were to examine the expressions of endothelium specific VE-cadherin, intestine specific LI-cadherin, and vascular endothelial growth factor (VEGF), and to determine their relationships with...
7.
Song H, Shim K, Joo Y, Kim S, Jung S, Yoo K
Gut Liver
. 2010 May;
2(2):119-25.
PMID: 20485621
Background/aims: RUNX3 (PEBP2alphaC/CBFA3/AML2) is a novel tumor suppressor gene in the human gastric carcinoma. The aims of this study were to determine the methylation of RUNX3 promoter and the association...
8.
Shin J, Jung S, Kim S, Joo Y, Shim K, Kim T, et al.
Korean J Gastroenterol
. 2008 Jan;
50(1):9-18.
PMID: 18172354
Background/aims: This study was aimed to investigate the expression of matrix metalloproteinase-2 (MMP-2), hypoxia-inducible factor (HIF)-1alpha, and vascular endothelial growth factor (VEGF) in colonic adenoma-carcinoma sequence. Methods: Thirty-two tissue samples...
9.
Shim K, Jung S, Joo Y, Yoo K
J Gastroenterol
. 2007 Mar;
42(2):120-8.
PMID: 17351800
Background: Matrix metalloproteinases (MMPs) are one of the major classes of proteolytic enzymes involved in tumor invasion and metastasis, being inhibited by naturally occurring tissue inhibitors of metalloproteinases (TIMPs). In...